What is the official website of Merck Animal Health ?

The official website of Merck Animal Health is https://www.merck-animal-health.com.

What is Merck Animal Health's cybersecurity risk score?

Merck Animal Health has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Merck Animal Health experienced?

According to Rankiteo, Merck Animal Health currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Merck Animal Health been affected by any supply chain cyber incidents ?

According to Rankiteo, Merck Animal Health has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Merck Animal Health have SOC 2 Type 1 certification ?

According to Rankiteo, Merck Animal Health is not certified under SOC 2 Type 1.

Does Merck Animal Health have SOC 2 Type 2 certification ?

According to Rankiteo, Merck Animal Health does not hold a SOC 2 Type 2 certification.

Does Merck Animal Health comply with GDPR ?

According to Rankiteo, Merck Animal Health is not listed as GDPR compliant.

Does Merck Animal Health have PCI DSS certification ?

According to Rankiteo, Merck Animal Health does not currently maintain PCI DSS compliance.

Does Merck Animal Health comply with HIPAA ?

According to Rankiteo, Merck Animal Health is not compliant with HIPAA regulations.

Does Merck Animal Health have ISO 27001 certification ?

According to Rankiteo,Merck Animal Health is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Merck Animal Health operate in ?

Merck Animal Health operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Merck Animal Health have ?

Merck Animal Health employs approximately 21 people worldwide.

Does Merck Animal Health own any subsidiaries ?

Merck Animal Health presently has no subsidiaries across any sectors.

How many LinkedIn followers does Merck Animal Health have ?

Merck Animal Health's official LinkedIn profile has approximately 165,706 followers.

What is the NAICS classification code for Merck Animal Health ?

Merck Animal Health is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Merck Animal Health have a Crunchbase profile ?

No, Merck Animal Health does not have a profile on Crunchbase.

Does Merck Animal Health have a LinkedIn profile ?

Yes, Merck Animal Health maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/merck-animal-health.

How many cybersecurity incidents has Merck Animal Health experienced ?

As of August 26, 2026, Rankiteo reports that Merck Animal Health has experienced 3 cybersecurity incidents.

How many peer or competitor companies does Merck Animal Health have ?

Merck Animal Health has an estimated 5,737 peer or competitor companies worldwide.

What types of cybersecurity incidents has Merck Animal Health faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Cyber Attack and Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MAH

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

Merck Animal Health Vendor Cyber Rating & Cyber Score

merck-animal-health.com

Add Your Compliance Badge

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business of Merck. Through our commitment to The Science of Healthier Animals®, we offer a wide range of veterinary medicines, vaccines and health management solutions and services, as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. This site is intended for residents of the United States and its territories only.

MAH A.I CyberSecurity Scoring

Scoring History

MAH

Merck Animal Health CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Merck Animal Health

Breach

9/2025

MER350243511182...

Merck

Cyber Attack

100

6/2025

MER1775377932

Merck Animal Health

Cyber Attack

06/2017

MER1502422

Loading…

A.I.

MAH Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MAH

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck Animal Health in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Merck Animal Health in 2026.

Incident Types MAH vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck Animal Health in 2026.

Incident History - MAH (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Merck Animal Health Subsidiaries

MAH

Pharmaceutical Manufacturing

Website: https://www.merck-animal-health.com

Company Size: 21

MerckPharmaceutical Manufacturing

Merck CanadaPharmaceutical Manufacturing

Loading…

Merck Animal Health Similar Companies

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Loading…

NEWS

Merck Animal Health CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 09, 2025 08:00 AM

FDA approves Merck drug for decimated U.S. cattle herds to stop screwworm

The U.S. Food and Drug Administration granted conditional approval for a Merck Animal Health pour-on treatment for the prevention and...

Read Article

December 04, 2025 08:00 AM

Merck (NYSE: MRK) gets FDA conditional OK for EXZOLT CATTLE-CA1 vs New World screwworm

FDA grants conditional approval for Merck Animal Health's EXZOLT CATTLE-CA1, a first-in-class isoxazoline pour-on for New World screwworm,...

Read Article

November 05, 2025 08:00 AM

3 Reasons Investors Love Merck (MRK)

Although Merck (currently trading at $84.57 per share) has gained 7% over the last six months, it has trailed the S&P 500's 21.3% return...

Read Article

October 30, 2025 07:00 AM

Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit

Merck reported third-quarter earnings and revenue that topped estimates in part due to strong demand for its cancer immunotherapy Keytruda,...

Read Article

October 30, 2025 07:00 AM

Merck & Co Inc (MRK) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges

Merck & Co Inc (MRK) reports a 4% revenue increase driven by Keytruda's demand, while facing headwinds in Gardasil sales and competitive...

Read Article

October 28, 2025 07:00 AM

Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings

Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings...

Read Article

October 13, 2025 07:00 AM

Indian American veterinarians hold annual meeting in Philadelphia

The Northeast Chapter of the American Association of Veterinarians of Indian Origin (AAVIO) held its annual regional meeting October 12,...

Read Article

October 02, 2025 07:00 AM

HEALTH CANADA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-release Injectable Suspension) from Merck Animal Health

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J.,...

Read Article

September 18, 2025 07:00 AM

Sai Life Sciences veterinary API expansion in India

Sai Life Sciences unveils a new veterinary API facility in India, expanding animal-health manufacturing capacity.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-80138

SUMMARY

ClipBucket V5's web installer fails to properly validate or escape the php_cli_filepath parameter before passing it to shell execution. Unauthenticated attackers can submit a crafted POST request to the installer with a malicious php_cli_filepath value to execute arbitrary commands as the web server user.

Published

Date2026-08-25

Updated

Date2026-08-25

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

3.9

REFERENCES

CVE-2026-79912

SUMMARY

A vulnerability was detected in TOTOLINK N600R 4.3.0cu.7647_B20210106. The impacted element is the function getCurrentTime of the file /cgi-bin/cstecgi.cgi. Performing a manipulation of the argument ntp_server results in command injection. The attack can be initiated remotely. The exploit is now public and may be used.

Published

Date2026-08-25

Updated

Date2026-08-25

RISK INFORMATION (Score: 8.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 8.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:L/SI:L/SA:L/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.7

Exploitability

3.9

REFERENCES

CVE-2026-79911

SUMMARY

A security vulnerability has been detected in TOTOLINK N600R 4.3.0cu.7647_B20210106. The affected element is the function setSystemConfig of the file /cgi-bin/cstecgi.cgi of the component CGI Handler. Such manipulation of the argument Hostname leads to stack-based buffer overflow. It is possible to launch the attack remotely. The exploit has been disclosed publicly and may be used.

Published

Date2026-08-25

Updated

Date2026-08-25

RISK INFORMATION (Score: 10)

cvss2

Base Score: 10.0

Complexity: LOW

AV:N/AC:L/Au:N/C:C/I:C/A:C

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

CVE-2026-70665

SUMMARY

Doorkeeper OpenID Connect implements an OpenID Connect authentication provider for Rails applications on top of Doorkeeper. Prior to 1.10.4, the Dynamic Client Registration (DCR) endpoint persists client-supplied scopes without validating them against the server's configured scope set. Under certain conditions, this allows a self-registered client to obtain scopes beyond what the server intended to grant. In DynamicClientRegistrationController#application_params, the scopes attribute is assigned directly from params[:scope] with no validation against Doorkeeper.configuration.scopes or optional_scopes. Combined with enforce_configured_scopes being off by default and Doorkeeper's ScopeChecker prioritizing application-level scopes over server-level scopes, this creates a privilege escalation path. This issue is fixed in version 1.10.4.

Published

Date2026-08-25

Updated

Date2026-08-25

RISK INFORMATION (Score: 4.2)

cvss3

Base Score: 4.2

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

1.6

REFERENCES

CVE-2026-55805

SUMMARY

Improper Neutralization of Input During Web Page Generation ("Cross-site Scripting") vulnerability in Drupal Drupal core allows Stored XSS. This issue affects Drupal core versions: from 0.0.0 to 10.6.13, from 11.3.0 to 11.3.14, from 11.4.0 to 11.4.4, from 0.0.0 to 11.0.*, from 0.0.0 to 11.1.*, from 0.0.0 to 11.2.*.

Published

Date2026-08-25

Updated

Date2026-08-25

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

https://www.drupal.org/sa-core-2026-012

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…